Scroll to top
- Manufacturer of advanced intermediates for patented APIs; supplier to marquee customers in regulated markets
- Contract manufacturer of APIs for patented drugs
- 3 USFDA approved plants (2 in Spain, 1 in Mexico)
- More than 47 DMF’s, 20 COS and franchise position in anti-ulcer segment
- The Fund has exited this investment.